BioCardia, Inc. Warrant
BCDAW
BCDAW was delisted on the 2nd of August, 2024.
5 hedge funds and large institutions have $177K invested in BioCardia, Inc. Warrant in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
72% less capital invested
Capital invested by funds: $641K → $177K (-$464K)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $151K | – | – | – |
|
2
Osaic Holdings
Scottsdale,
Arizona
| $16K | – | – | – |
|
|
EAM
3
Empery Asset Management
New York
| $8K | – | – | – |
|
4
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
BCDAW Hedge Fund Activity: Q1 2022 in Review
5 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q1 2022, worth a combined $177K — down 72% from $641K a quarter earlier.
Fund positioning in BCDAW was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 5 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $177K of BioCardia, Inc. Warrant stock for Q1 2022, down 72% quarter-over-quarter.
- 0 funds opened new BioCardia, Inc. Warrant positions in Q1 2022 and 0 closed out.
Based on aggregated 13F filings for Q1 2022.